nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—PDE5A—Pentoxifylline—systemic scleroderma	0.672	0.916	CbGbCtD
Vardenafil—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0362	0.0494	CbGbCtD
Vardenafil—PDE5A—pulmonary artery—systemic scleroderma	0.015	0.272	CbGeAlD
Vardenafil—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0141	0.0193	CbGbCtD
Vardenafil—CYP3A4—Prednisone—systemic scleroderma	0.0113	0.0154	CbGbCtD
Vardenafil—PDE5A—artery—systemic scleroderma	0.00558	0.101	CbGeAlD
Vardenafil—PDE5A—endothelium—systemic scleroderma	0.00471	0.0853	CbGeAlD
Vardenafil—PDE5A—blood vessel—systemic scleroderma	0.00435	0.0786	CbGeAlD
Vardenafil—PDE11A—tendon—systemic scleroderma	0.00403	0.0728	CbGeAlD
Vardenafil—PDE6G—lung—systemic scleroderma	0.0034	0.0615	CbGeAlD
Vardenafil—PDE10A—digestive system—systemic scleroderma	0.00275	0.0498	CbGeAlD
Vardenafil—PDE10A—tendon—systemic scleroderma	0.00262	0.0474	CbGeAlD
Vardenafil—PDE10A—lung—systemic scleroderma	0.0023	0.0416	CbGeAlD
Vardenafil—PDE5A—connective tissue—systemic scleroderma	0.00223	0.0403	CbGeAlD
Vardenafil—PDE5A—smooth muscle tissue—systemic scleroderma	0.00204	0.0369	CbGeAlD
Vardenafil—PDE5A—digestive system—systemic scleroderma	0.00161	0.0291	CbGeAlD
Vardenafil—PDE5A—tendon—systemic scleroderma	0.00153	0.0277	CbGeAlD
Vardenafil—PDE5A—lung—systemic scleroderma	0.00134	0.0243	CbGeAlD
Vardenafil—CYP3A5—digestive system—systemic scleroderma	0.000668	0.0121	CbGeAlD
Vardenafil—CYP3A5—lung—systemic scleroderma	0.000558	0.0101	CbGeAlD
Vardenafil—CYP3A4—digestive system—systemic scleroderma	0.000502	0.00908	CbGeAlD
Vardenafil—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000234	0.0011	CcSEcCtD
Vardenafil—Dyspnoea—Leflunomide—systemic scleroderma	0.000233	0.0011	CcSEcCtD
Vardenafil—Hypotension—Mycophenolic acid—systemic scleroderma	0.000233	0.0011	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000233	0.0011	CcSEcCtD
Vardenafil—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000232	0.0011	CcSEcCtD
Vardenafil—Discomfort—Lisinopril—systemic scleroderma	0.000232	0.0011	CcSEcCtD
Vardenafil—Dyspepsia—Leflunomide—systemic scleroderma	0.00023	0.00109	CcSEcCtD
Vardenafil—Vomiting—Mometasone—systemic scleroderma	0.00023	0.00109	CcSEcCtD
Vardenafil—Dry mouth—Lisinopril—systemic scleroderma	0.000229	0.00108	CcSEcCtD
Vardenafil—Feeling abnormal—Azathioprine—systemic scleroderma	0.000228	0.00108	CcSEcCtD
Vardenafil—Rash—Mometasone—systemic scleroderma	0.000228	0.00108	CcSEcCtD
Vardenafil—Asthenia—Captopril—systemic scleroderma	0.000228	0.00108	CcSEcCtD
Vardenafil—Dermatitis—Mometasone—systemic scleroderma	0.000228	0.00108	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000227	0.00108	CcSEcCtD
Vardenafil—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000227	0.00107	CcSEcCtD
Vardenafil—Headache—Mometasone—systemic scleroderma	0.000226	0.00107	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000226	0.00107	CcSEcCtD
Vardenafil—Insomnia—Mycophenolic acid—systemic scleroderma	0.000226	0.00107	CcSEcCtD
Vardenafil—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000225	0.00106	CcSEcCtD
Vardenafil—Pruritus—Captopril—systemic scleroderma	0.000225	0.00106	CcSEcCtD
Vardenafil—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000224	0.00106	CcSEcCtD
Vardenafil—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000224	0.00106	CcSEcCtD
Vardenafil—Pain—Leflunomide—systemic scleroderma	0.000224	0.00106	CcSEcCtD
Vardenafil—Infection—Lisinopril—systemic scleroderma	0.000223	0.00106	CcSEcCtD
Vardenafil—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000223	0.00105	CcSEcCtD
Vardenafil—Somnolence—Mycophenolic acid—systemic scleroderma	0.000222	0.00105	CcSEcCtD
Vardenafil—Shock—Lisinopril—systemic scleroderma	0.000221	0.00105	CcSEcCtD
Vardenafil—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00104	CcSEcCtD
Vardenafil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00022	0.00104	CcSEcCtD
Vardenafil—Tachycardia—Lisinopril—systemic scleroderma	0.000219	0.00104	CcSEcCtD
Vardenafil—Abdominal pain—Azathioprine—systemic scleroderma	0.000219	0.00104	CcSEcCtD
Vardenafil—Skin disorder—Lisinopril—systemic scleroderma	0.000218	0.00103	CcSEcCtD
Vardenafil—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00103	CcSEcCtD
Vardenafil—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000217	0.00103	CcSEcCtD
Vardenafil—Diarrhoea—Captopril—systemic scleroderma	0.000217	0.00103	CcSEcCtD
Vardenafil—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00103	CcSEcCtD
Vardenafil—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000216	0.00102	CcSEcCtD
Vardenafil—Feeling abnormal—Leflunomide—systemic scleroderma	0.000216	0.00102	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000216	0.00102	CcSEcCtD
Vardenafil—Nausea—Mometasone—systemic scleroderma	0.000215	0.00101	CcSEcCtD
Vardenafil—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000214	0.00101	CcSEcCtD
Vardenafil—Pain—Mycophenolic acid—systemic scleroderma	0.000213	0.00101	CcSEcCtD
Vardenafil—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000213	0.00101	CcSEcCtD
Vardenafil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000212	0.001	CcSEcCtD
Vardenafil—Hypotension—Lisinopril—systemic scleroderma	0.00021	0.000993	CcSEcCtD
Vardenafil—Dizziness—Captopril—systemic scleroderma	0.00021	0.000992	CcSEcCtD
Vardenafil—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00021	0.000991	CcSEcCtD
Vardenafil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000989	CcSEcCtD
Vardenafil—Abdominal pain—Leflunomide—systemic scleroderma	0.000207	0.000978	CcSEcCtD
Vardenafil—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000206	0.000976	CcSEcCtD
Vardenafil—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000206	0.000972	CcSEcCtD
Vardenafil—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000971	CcSEcCtD
Vardenafil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000971	CcSEcCtD
Vardenafil—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000971	CcSEcCtD
Vardenafil—Myocardial infarction—Prednisone—systemic scleroderma	0.000205	0.00097	CcSEcCtD
Vardenafil—Breast disorder—Methotrexate—systemic scleroderma	0.000205	0.00097	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000205	0.000968	CcSEcCtD
Vardenafil—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000968	CcSEcCtD
Vardenafil—Hypersensitivity—Azathioprine—systemic scleroderma	0.000204	0.000965	CcSEcCtD
Vardenafil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000204	0.000965	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000965	CcSEcCtD
Vardenafil—Insomnia—Lisinopril—systemic scleroderma	0.000203	0.000961	CcSEcCtD
Vardenafil—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000203	0.00096	CcSEcCtD
Vardenafil—Paraesthesia—Lisinopril—systemic scleroderma	0.000202	0.000954	CcSEcCtD
Vardenafil—Vomiting—Captopril—systemic scleroderma	0.000202	0.000954	CcSEcCtD
Vardenafil—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000201	0.00095	CcSEcCtD
Vardenafil—Dyspnoea—Lisinopril—systemic scleroderma	0.0002	0.000948	CcSEcCtD
Vardenafil—Rash—Captopril—systemic scleroderma	0.0002	0.000946	CcSEcCtD
Vardenafil—Dermatitis—Captopril—systemic scleroderma	0.0002	0.000945	CcSEcCtD
Vardenafil—Somnolence—Lisinopril—systemic scleroderma	0.0002	0.000945	CcSEcCtD
Vardenafil—Headache—Captopril—systemic scleroderma	0.000199	0.00094	CcSEcCtD
Vardenafil—Dyspepsia—Lisinopril—systemic scleroderma	0.000198	0.000936	CcSEcCtD
Vardenafil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000197	0.000933	CcSEcCtD
Vardenafil—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000931	CcSEcCtD
Vardenafil—Infection—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000925	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000194	0.000918	CcSEcCtD
Vardenafil—Shock—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000916	CcSEcCtD
Vardenafil—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000913	CcSEcCtD
Vardenafil—Hypersensitivity—Leflunomide—systemic scleroderma	0.000193	0.000911	CcSEcCtD
Vardenafil—Pain—Lisinopril—systemic scleroderma	0.000192	0.000909	CcSEcCtD
Vardenafil—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000909	CcSEcCtD
Vardenafil—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000905	CcSEcCtD
Vardenafil—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00019	0.0009	CcSEcCtD
Vardenafil—Diarrhoea—Azathioprine—systemic scleroderma	0.00019	0.000896	CcSEcCtD
Vardenafil—Haemoglobin—Prednisone—systemic scleroderma	0.000189	0.000893	CcSEcCtD
Vardenafil—Nausea—Captopril—systemic scleroderma	0.000189	0.000891	CcSEcCtD
Vardenafil—Haemorrhage—Prednisone—systemic scleroderma	0.000188	0.000888	CcSEcCtD
Vardenafil—Asthenia—Leflunomide—systemic scleroderma	0.000188	0.000887	CcSEcCtD
Vardenafil—Feeling abnormal—Lisinopril—systemic scleroderma	0.000185	0.000876	CcSEcCtD
Vardenafil—Pruritus—Leflunomide—systemic scleroderma	0.000185	0.000875	CcSEcCtD
Vardenafil—Connective tissue disorder—Prednisone—systemic scleroderma	0.000185	0.000873	CcSEcCtD
Vardenafil—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00087	CcSEcCtD
Vardenafil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000184	0.000869	CcSEcCtD
Vardenafil—Dizziness—Azathioprine—systemic scleroderma	0.000183	0.000866	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000848	CcSEcCtD
Vardenafil—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000179	0.000847	CcSEcCtD
Vardenafil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000179	0.000847	CcSEcCtD
Vardenafil—Diarrhoea—Leflunomide—systemic scleroderma	0.000179	0.000846	CcSEcCtD
Vardenafil—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000842	CcSEcCtD
Vardenafil—Abdominal pain—Lisinopril—systemic scleroderma	0.000178	0.00084	CcSEcCtD
Vardenafil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000836	CcSEcCtD
Vardenafil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000177	0.000835	CcSEcCtD
Vardenafil—Vomiting—Azathioprine—systemic scleroderma	0.000176	0.000833	CcSEcCtD
Vardenafil—Eye disorder—Prednisone—systemic scleroderma	0.000176	0.00083	CcSEcCtD
Vardenafil—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00083	CcSEcCtD
Vardenafil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000828	CcSEcCtD
Vardenafil—Infestation NOS—Methotrexate—systemic scleroderma	0.000175	0.000827	CcSEcCtD
Vardenafil—Infestation—Methotrexate—systemic scleroderma	0.000175	0.000827	CcSEcCtD
Vardenafil—Rash—Azathioprine—systemic scleroderma	0.000175	0.000826	CcSEcCtD
Vardenafil—Dermatitis—Azathioprine—systemic scleroderma	0.000175	0.000825	CcSEcCtD
Vardenafil—Flushing—Prednisone—systemic scleroderma	0.000174	0.000825	CcSEcCtD
Vardenafil—Headache—Azathioprine—systemic scleroderma	0.000174	0.000821	CcSEcCtD
Vardenafil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000173	0.00082	CcSEcCtD
Vardenafil—Dizziness—Leflunomide—systemic scleroderma	0.000173	0.000818	CcSEcCtD
Vardenafil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000171	0.000807	CcSEcCtD
Vardenafil—Angiopathy—Prednisone—systemic scleroderma	0.000171	0.000806	CcSEcCtD
Vardenafil—Conjunctivitis—Methotrexate—systemic scleroderma	0.00017	0.000804	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000804	CcSEcCtD
Vardenafil—Immune system disorder—Prednisone—systemic scleroderma	0.00017	0.000803	CcSEcCtD
Vardenafil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000796	CcSEcCtD
Vardenafil—Sweating—Methotrexate—systemic scleroderma	0.000168	0.000793	CcSEcCtD
Vardenafil—Haematuria—Methotrexate—systemic scleroderma	0.000167	0.000789	CcSEcCtD
Vardenafil—Vomiting—Leflunomide—systemic scleroderma	0.000166	0.000786	CcSEcCtD
Vardenafil—Hypersensitivity—Lisinopril—systemic scleroderma	0.000166	0.000783	CcSEcCtD
Vardenafil—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000166	0.000782	CcSEcCtD
Vardenafil—Dizziness—Mycophenolic acid—systemic scleroderma	0.000165	0.00078	CcSEcCtD
Vardenafil—Epistaxis—Methotrexate—systemic scleroderma	0.000165	0.00078	CcSEcCtD
Vardenafil—Rash—Leflunomide—systemic scleroderma	0.000165	0.00078	CcSEcCtD
Vardenafil—Dermatitis—Leflunomide—systemic scleroderma	0.000165	0.000779	CcSEcCtD
Vardenafil—Mental disorder—Prednisone—systemic scleroderma	0.000165	0.000778	CcSEcCtD
Vardenafil—Nausea—Azathioprine—systemic scleroderma	0.000165	0.000778	CcSEcCtD
Vardenafil—Headache—Leflunomide—systemic scleroderma	0.000164	0.000775	CcSEcCtD
Vardenafil—Erythema—Prednisone—systemic scleroderma	0.000164	0.000773	CcSEcCtD
Vardenafil—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000767	CcSEcCtD
Vardenafil—Asthenia—Lisinopril—systemic scleroderma	0.000161	0.000763	CcSEcCtD
Vardenafil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000761	CcSEcCtD
Vardenafil—Pruritus—Lisinopril—systemic scleroderma	0.000159	0.000752	CcSEcCtD
Vardenafil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000159	0.00075	CcSEcCtD
Vardenafil—Haemoglobin—Methotrexate—systemic scleroderma	0.000158	0.000746	CcSEcCtD
Vardenafil—Rash—Mycophenolic acid—systemic scleroderma	0.000157	0.000744	CcSEcCtD
Vardenafil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000157	0.000743	CcSEcCtD
Vardenafil—Haemorrhage—Methotrexate—systemic scleroderma	0.000157	0.000743	CcSEcCtD
Vardenafil—Headache—Mycophenolic acid—systemic scleroderma	0.000156	0.000739	CcSEcCtD
Vardenafil—Pharyngitis—Methotrexate—systemic scleroderma	0.000156	0.000737	CcSEcCtD
Vardenafil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000736	CcSEcCtD
Vardenafil—Nausea—Leflunomide—systemic scleroderma	0.000155	0.000735	CcSEcCtD
Vardenafil—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000155	0.000733	CcSEcCtD
Vardenafil—Vision blurred—Prednisone—systemic scleroderma	0.000154	0.000729	CcSEcCtD
Vardenafil—Urethral disorder—Methotrexate—systemic scleroderma	0.000154	0.000728	CcSEcCtD
Vardenafil—Diarrhoea—Lisinopril—systemic scleroderma	0.000154	0.000727	CcSEcCtD
Vardenafil—Ill-defined disorder—Prednisone—systemic scleroderma	0.000152	0.000718	CcSEcCtD
Vardenafil—Visual impairment—Methotrexate—systemic scleroderma	0.000151	0.000716	CcSEcCtD
Vardenafil—Angioedema—Prednisone—systemic scleroderma	0.00015	0.000707	CcSEcCtD
Vardenafil—Dizziness—Lisinopril—systemic scleroderma	0.000149	0.000703	CcSEcCtD
Vardenafil—Nausea—Mycophenolic acid—systemic scleroderma	0.000148	0.000701	CcSEcCtD
Vardenafil—Malaise—Prednisone—systemic scleroderma	0.000148	0.000697	CcSEcCtD
Vardenafil—Vertigo—Prednisone—systemic scleroderma	0.000147	0.000695	CcSEcCtD
Vardenafil—Eye disorder—Methotrexate—systemic scleroderma	0.000147	0.000694	CcSEcCtD
Vardenafil—Syncope—Prednisone—systemic scleroderma	0.000147	0.000694	CcSEcCtD
Vardenafil—Tinnitus—Methotrexate—systemic scleroderma	0.000146	0.000692	CcSEcCtD
Vardenafil—Cardiac disorder—Methotrexate—systemic scleroderma	0.000146	0.000689	CcSEcCtD
Vardenafil—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000686	CcSEcCtD
Vardenafil—Loss of consciousness—Prednisone—systemic scleroderma	0.000144	0.00068	CcSEcCtD
Vardenafil—Vomiting—Lisinopril—systemic scleroderma	0.000143	0.000676	CcSEcCtD
Vardenafil—Angiopathy—Methotrexate—systemic scleroderma	0.000143	0.000674	CcSEcCtD
Vardenafil—Immune system disorder—Methotrexate—systemic scleroderma	0.000142	0.000671	CcSEcCtD
Vardenafil—Rash—Lisinopril—systemic scleroderma	0.000142	0.00067	CcSEcCtD
Vardenafil—Convulsion—Prednisone—systemic scleroderma	0.000142	0.00067	CcSEcCtD
Vardenafil—Dermatitis—Lisinopril—systemic scleroderma	0.000142	0.00067	CcSEcCtD
Vardenafil—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000142	0.000669	CcSEcCtD
Vardenafil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000668	CcSEcCtD
Vardenafil—Headache—Lisinopril—systemic scleroderma	0.000141	0.000666	CcSEcCtD
Vardenafil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000659	CcSEcCtD
Vardenafil—Arthralgia—Prednisone—systemic scleroderma	0.000139	0.000658	CcSEcCtD
Vardenafil—Myalgia—Prednisone—systemic scleroderma	0.000139	0.000658	CcSEcCtD
Vardenafil—Anxiety—Prednisone—systemic scleroderma	0.000139	0.000656	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000138	0.000654	CcSEcCtD
Vardenafil—Discomfort—Prednisone—systemic scleroderma	0.000138	0.000651	CcSEcCtD
Vardenafil—Mental disorder—Methotrexate—systemic scleroderma	0.000138	0.000651	CcSEcCtD
Vardenafil—Erythema—Methotrexate—systemic scleroderma	0.000137	0.000646	CcSEcCtD
Vardenafil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000637	CcSEcCtD
Vardenafil—Nausea—Lisinopril—systemic scleroderma	0.000134	0.000631	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisone—systemic scleroderma	0.000134	0.000631	CcSEcCtD
Vardenafil—Infection—Prednisone—systemic scleroderma	0.000133	0.000627	CcSEcCtD
Vardenafil—Back pain—Methotrexate—systemic scleroderma	0.000132	0.000625	CcSEcCtD
Vardenafil—Shock—Prednisone—systemic scleroderma	0.000131	0.000621	CcSEcCtD
Vardenafil—Nervous system disorder—Prednisone—systemic scleroderma	0.000131	0.000619	CcSEcCtD
Vardenafil—Tachycardia—Prednisone—systemic scleroderma	0.00013	0.000616	CcSEcCtD
Vardenafil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000616	CcSEcCtD
Vardenafil—Skin disorder—Prednisone—systemic scleroderma	0.00013	0.000613	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisone—systemic scleroderma	0.000129	0.00061	CcSEcCtD
Vardenafil—Vision blurred—Methotrexate—systemic scleroderma	0.000129	0.000609	CcSEcCtD
Vardenafil—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000127	0.0006	CcSEcCtD
Vardenafil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000592	CcSEcCtD
Vardenafil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000587	CcSEcCtD
Vardenafil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000587	CcSEcCtD
Vardenafil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000583	CcSEcCtD
Vardenafil—Malaise—Methotrexate—systemic scleroderma	0.000123	0.000583	CcSEcCtD
Vardenafil—Vertigo—Methotrexate—systemic scleroderma	0.000123	0.000581	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000122	0.000575	CcSEcCtD
Vardenafil—Insomnia—Prednisone—systemic scleroderma	0.000121	0.000571	CcSEcCtD
Vardenafil—Paraesthesia—Prednisone—systemic scleroderma	0.00012	0.000567	CcSEcCtD
Vardenafil—Convulsion—Methotrexate—systemic scleroderma	0.000118	0.00056	CcSEcCtD
Vardenafil—Dyspepsia—Prednisone—systemic scleroderma	0.000118	0.000556	CcSEcCtD
Vardenafil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000553	CcSEcCtD
Vardenafil—Arthralgia—Methotrexate—systemic scleroderma	0.000116	0.00055	CcSEcCtD
Vardenafil—Chest pain—Methotrexate—systemic scleroderma	0.000116	0.00055	CcSEcCtD
Vardenafil—Myalgia—Methotrexate—systemic scleroderma	0.000116	0.00055	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000116	0.000547	CcSEcCtD
Vardenafil—Discomfort—Methotrexate—systemic scleroderma	0.000115	0.000544	CcSEcCtD
Vardenafil—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000112	0.000528	CcSEcCtD
Vardenafil—Infection—Methotrexate—systemic scleroderma	0.000111	0.000524	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisone—systemic scleroderma	0.00011	0.00052	CcSEcCtD
Vardenafil—Nervous system disorder—Methotrexate—systemic scleroderma	0.000109	0.000517	CcSEcCtD
Vardenafil—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000109	0.000516	CcSEcCtD
Vardenafil—Skin disorder—Methotrexate—systemic scleroderma	0.000108	0.000512	CcSEcCtD
Vardenafil—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000108	0.00051	CcSEcCtD
Vardenafil—Abdominal pain—Prednisone—systemic scleroderma	0.000106	0.000499	CcSEcCtD
Vardenafil—Hypotension—Methotrexate—systemic scleroderma	0.000104	0.000493	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000102	0.000481	CcSEcCtD
Vardenafil—Insomnia—Methotrexate—systemic scleroderma	0.000101	0.000477	CcSEcCtD
Vardenafil—Paraesthesia—Methotrexate—systemic scleroderma	0.0001	0.000474	CcSEcCtD
Vardenafil—Dyspnoea—Methotrexate—systemic scleroderma	9.95e-05	0.00047	CcSEcCtD
Vardenafil—Somnolence—Methotrexate—systemic scleroderma	9.92e-05	0.000469	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisone—systemic scleroderma	9.84e-05	0.000465	CcSEcCtD
Vardenafil—Dyspepsia—Methotrexate—systemic scleroderma	9.83e-05	0.000464	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	9.64e-05	0.000455	CcSEcCtD
Vardenafil—Asthenia—Prednisone—systemic scleroderma	9.58e-05	0.000453	CcSEcCtD
Vardenafil—Pain—Methotrexate—systemic scleroderma	9.54e-05	0.000451	CcSEcCtD
Vardenafil—Pruritus—Prednisone—systemic scleroderma	9.45e-05	0.000447	CcSEcCtD
Vardenafil—Feeling abnormal—Methotrexate—systemic scleroderma	9.2e-05	0.000435	CcSEcCtD
Vardenafil—Diarrhoea—Prednisone—systemic scleroderma	9.14e-05	0.000432	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methotrexate—systemic scleroderma	9.13e-05	0.000431	CcSEcCtD
Vardenafil—Dizziness—Prednisone—systemic scleroderma	8.83e-05	0.000417	CcSEcCtD
Vardenafil—Abdominal pain—Methotrexate—systemic scleroderma	8.82e-05	0.000417	CcSEcCtD
Vardenafil—Vomiting—Prednisone—systemic scleroderma	8.49e-05	0.000401	CcSEcCtD
Vardenafil—Rash—Prednisone—systemic scleroderma	8.42e-05	0.000398	CcSEcCtD
Vardenafil—Dermatitis—Prednisone—systemic scleroderma	8.41e-05	0.000398	CcSEcCtD
Vardenafil—Headache—Prednisone—systemic scleroderma	8.37e-05	0.000395	CcSEcCtD
Vardenafil—Hypersensitivity—Methotrexate—systemic scleroderma	8.22e-05	0.000389	CcSEcCtD
Vardenafil—Asthenia—Methotrexate—systemic scleroderma	8.01e-05	0.000378	CcSEcCtD
Vardenafil—Nausea—Prednisone—systemic scleroderma	7.93e-05	0.000375	CcSEcCtD
Vardenafil—Pruritus—Methotrexate—systemic scleroderma	7.9e-05	0.000373	CcSEcCtD
Vardenafil—Diarrhoea—Methotrexate—systemic scleroderma	7.64e-05	0.000361	CcSEcCtD
Vardenafil—Dizziness—Methotrexate—systemic scleroderma	7.38e-05	0.000349	CcSEcCtD
Vardenafil—Vomiting—Methotrexate—systemic scleroderma	7.1e-05	0.000335	CcSEcCtD
Vardenafil—Rash—Methotrexate—systemic scleroderma	7.04e-05	0.000333	CcSEcCtD
Vardenafil—Dermatitis—Methotrexate—systemic scleroderma	7.03e-05	0.000332	CcSEcCtD
Vardenafil—Headache—Methotrexate—systemic scleroderma	6.99e-05	0.00033	CcSEcCtD
Vardenafil—Nausea—Methotrexate—systemic scleroderma	6.63e-05	0.000313	CcSEcCtD
